Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: Relationship between clinical features and immunohistochemical changes

被引:46
作者
De Falco, Marianna [1 ]
Staibano, Stefania [2 ]
Mascolo, Massimo [2 ]
Mignogna, Chiara [2 ]
Improda, Luigi [1 ]
Ciociola, Francesca [1 ]
Carbone, Ilma F. [1 ]
Di Lieto, Andrea [1 ]
机构
[1] Univ Naples Federico 2, Dept Obstet Gynaecol & Urol Sci & Reprod Med, I-80131 Naples, Italy
[2] Univ Naples Federico 2, Dept Biomorphol & Funct Sci, I-80131 Naples, Italy
关键词
Cleavage plan; GnRH-a therapy; Intraoperative blood loss; Leiomyoma pseudocapsule; Myomectomy; UTERINE LEIOMYOMAS; ABDOMINAL MYOMECTOMY; LEUPROLIDE ACETATE; GROWTH-FACTOR; EXPRESSION; PROLIFERATION; APOPTOSIS; BCL-2;
D O I
10.1016/j.ejogrb.2009.02.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate if pre-operative GnRH-a modify uterine leiomyoma pseudocapsule and the possible clinical effects of these changes. Study design: The study was performed at the University Federico II of Naples on 33 premenopausal patients submitted to laparotomic myomectomy after treatment with triptorelin depot. 29 untreated patients formed the control group. The operating time, the intraoperative bleeding and the prompt identification of the cleavage plan between myoma and myometrium were evaluated. The pseudocapsule features and the immunoexpression of PCNA and CD34 in this area were studied. Results: Treated patients showed lower blood loss and not clearly identifiable cleavage plan, but without any significant increase in the operating time. Treated lesions showed less evident border between myoma and myometrium and lower PCNA and CD34 pseudocapsule immunoexpression than untreated ones. Conclusion: We propose the changes of leiomyoma pseudocapsule as partial explanations of the reported clinical and surgical findings after pre-operative GnRH-a. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:44 / 47
页数:4
相关论文
共 16 条
[1]   Abdominal myomectomy: Results of a simple operative technique [J].
Acien, P ;
Quereda, F .
FERTILITY AND STERILITY, 1996, 65 (01) :41-51
[2]  
BEYTH Y, 1990, FERTIL STERIL, V53, P187
[3]   Expression of proliferating cell nuclear antigen and Bcl-2 during a pseudomenopausal state induced by presurgical treatment of uterine leiomyomas with gonadotropin-releasing hormone analogues plus tibolone [J].
De Falco, M ;
Staibano, S ;
Pollio, F ;
Salvatore, G ;
Pontillo, M ;
Ciociola, F ;
Mansueto, G ;
Di Lieto, A .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (03) :286-291
[4]   Preoperative treatment of uterine leiomyomas:: Clinical findings and expression of transforming growth factor-β3 and connective tissue growth factor [J].
De Falco, Marianna ;
Staibano, Stefania ;
D'Armiento, Francesco Paolo ;
Mascolo, Massimo ;
Salvatore, Gaetano ;
Busiello, Anna ;
Carbone, Ilma Floriana ;
Pollio, Fabrizio ;
Di Lieto, Andrea .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (04) :297-303
[5]   Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas [J].
Di Lieto, A ;
De Falco, M ;
Pollio, F ;
Mansueto, G ;
Salvatore, G ;
Somma, P ;
Ciociola, F ;
De Rosa, G ;
Staibano, S .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) :123-128
[6]   Effects of gonadotropin-releasing hormone agonists on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas [J].
Di Lieto, A ;
De Falco, M ;
Staibano, S ;
Iannotti, F ;
Scaramellino, M ;
Salvatore, G ;
Mansueto, G ;
Granata, P ;
Pontillo, M ;
Pollio, F ;
De Rosa, G .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (04) :353-358
[7]   Laparoscopic myomectomy: predicting the risk of conversion to an open procedure [J].
Dubuisson, JB ;
Fauconnier, A ;
Fourchotte, V ;
Babaki-Fard, K ;
Coste, J ;
Chapron, C .
HUMAN REPRODUCTION, 2001, 16 (08) :1726-1731
[8]   Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist [J].
Huang, SC ;
Chou, CY ;
Lin, YS ;
Tsai, YC ;
Hsu, KF ;
Liu, CH ;
Huang, KE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (02) :417-424
[9]  
LETHABY A, 2007, COCHRANE LIB
[10]  
MARTIUS H, 1953, TRATTATO GINECOLOGIA